Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model
- PMID: 6896768
- DOI: 10.1126/science.6896768
Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model
Abstract
The substantial increases of hepatic, splenic, and renal heme oxygenase levels that occur shortly after birth in neonatal rats were prevented by a single administration of tin-protoporphyrin (10 micromoles per kilogram of body weight). With this treatment serum bilirubin levels declined within 24 hours to near-normal adult levels and remained low throughout the postnatal period. Zinc-protoporphyrin at doses up to 50-fold greater than the effective dose of tin-protoporphyrin did not prevent the immediate increases in tissue heme oxygenase activities and in serum bilirubin levels that occur postnatally. Studies in vitro with microsomal heme oxygenase in human spleen indicate that tin-protoporphyrin is a potent competitive inhibitor of the oxidation of heme to bile pigment in this tissue.
Similar articles
-
Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.Proc Natl Acad Sci U S A. 1981 Oct;78(10):6466-70. doi: 10.1073/pnas.78.10.6466. Proc Natl Acad Sci U S A. 1981. PMID: 6947237 Free PMC article.
-
Effect of tin protoporphyrin on the excretion rate of carbon monoxide in newborn rats after hematoma formation.J Pediatr Gastroenterol Nutr. 1985 Aug;4(4):650-4. doi: 10.1097/00005176-198508000-00027. J Pediatr Gastroenterol Nutr. 1985. PMID: 3839847
-
Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism.Arch Biochem Biophys. 1987 May 15;255(1):64-74. doi: 10.1016/0003-9861(87)90294-3. Arch Biochem Biophys. 1987. PMID: 3592668
-
Tin-metalloporphyrins: an answer to neonatal jaundice?Neonatal Netw. 1998 Aug;17(5):11-7; quiz 18-9. Neonatal Netw. 1998. PMID: 9791442 Review.
-
The use of metalloporphyrins for the chemoprevention of neonatal jaundice.Am J Dis Child. 1989 Mar;143(3):353-6. doi: 10.1001/archpedi.1989.02150150111027. Am J Dis Child. 1989. PMID: 2644817 Review.
Cited by
-
Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis.Gut. 1990 Aug;31(8):899-904. doi: 10.1136/gut.31.8.899. Gut. 1990. PMID: 2387514 Free PMC article.
-
HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage.Bone. 2010 Jan;46(1):236-43. doi: 10.1016/j.bone.2009.10.012. Epub 2009 Oct 21. Bone. 2010. PMID: 19853072 Free PMC article.
-
Hematin-derived anticoagulant. Generation in vitro and in vivo.J Exp Med. 1986 Mar 1;163(3):724-39. doi: 10.1084/jem.163.3.724. J Exp Med. 1986. PMID: 3950544 Free PMC article.
-
Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review.Int J Pediatr. 2022 Jul 18;2022:2549161. doi: 10.1155/2022/2549161. eCollection 2022. Int J Pediatr. 2022. PMID: 35898803 Free PMC article. Review.
-
"Light" on Phototherapy-Complications and Strategies for Shortening Its Duration, A Review of the Literature.Children (Basel). 2023 Oct 17;10(10):1699. doi: 10.3390/children10101699. Children (Basel). 2023. PMID: 37892362 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources